Biopharma Group Articles & Resources

Opening in Quarter 4, 2023, Biopharma Group’s new GMP freeze drying facility is set to provide a much needed resource to pharmaceutical companies needing small batch production facilities for first-in-human trials. With construction having started in January of 2023, the new GMP facility in Winchester, UK, will provide freeze drying for up to 3,200 2R vials in their state-of-the-art VirTis S10 freeze dryer, along with full isolation facilities in a grade A cleanroom environment for sterile production of both liquid and lyophilised products.

Freeze drying pharma and diagnostic products is essential in the bioprocessing industry but compared to many other pharmaceuticals, freeze drying cytotoxic agents carries additional risk. How can we carry out lyophilisation of cytotoxic drugs while ensuring the safety of all involved?

Biopharma Group has taken its extensive experience within the freeze drying industry to help increase lyophilization productivity, reduce costs and reduce cycle times by investing in its lyobead production capabilities. Biopharma Group’s lyobead generation line can create millions of lyobeads a month.

Freeze drying has become a popular technique across a variety of industries including, but not limited to diagnostics, pharmaceutical, biotech, and food to name a few, all of whom use freeze drying in the processing of their products in different ways.